【24h】

GWAS here, last year

机译:去年,GWAS在这里

获取原文
获取原文并翻译 | 示例
           

摘要

Often, at the start of a new year, a journal editor tends to prelude on what this year might bring. In this case, however, I would like to reflect on the past year. Indeed, a major development in the field of Human Genetics has been is the arrival of the Genome-Wide Association Studies or GWAS. Many previous years have seen reports of GWAS, and a frequently heard complaint has been, with some exceptions, that the findings were met with irregular or downright controversial replication results. If anything, the year 2007 has been the year of the publication of a large amount of rapidly and widely replicated GWAS. Notably, this has taken place in the field of diabetes, with now over 20 loci identified in total. The largest harvest for 1 year reaped by type 2 diabetes with now in total 11 loci confidently identified, six of which last year by GWAS; type 1 coming in second, with five loci last year on a total of 11 as well, and additional loci for prostate cancer and rheumatoid arthritis, the latter replicated in parallel by candidate gene analysis. And with bonuses coming along: dissection for body mass index has yielded the first obesity gene, FTO, the prostate cancer risk allele is protective for type 2 diabetes, and some type 2 diabetes risk genes when highly expressed, looks like predisposing for colon cancer when poorly expressed. These findings - and I count on correspondence telling us that we overlooked other examples - supports the concept, of connectivity: our biology does not respect classical clinical discipline boundaries, and the key switches are rather involved in maintaining balance, with quite different pathology following dearth or excess. The main accelerator of these breakthroughshas been the development of the HapMap resource and the Perlegen SNP set, heirs of the early days SNP consortium. All in the wake of the Human Genome Project, resulting, within half a decade, in robust, very high-density SNP detection platforms of Affymetrix and Illumina. And as each of these is derived fromthe same HapMap set, tools have already been developed to jointly analyse large study samples typed by either platform by imputation, computing missing values by interpolation (eg, Servin and Stephens).
机译:通常,在新的一年开始时,期刊编辑往往会为今年可能带来的前奏作序。但是,在这种情况下,我想回顾一下过去的一年。确实,人类基因学领域的一项重大发展是全基因组关联研究或GWAS的到来。过去许多年中都曾见过关于GWAS的报道,除了一些例外,经常听到的抱怨是,这些发现遇到了不规则或彻头彻尾的有争议的复制结果。如果有的话,2007年是发布大量快速且广泛复制的GWAS的一年。值得注意的是,这已经发生在糖尿病领域,目前总共鉴定出20多个基因座。 2型糖尿病是1年以来最大的收获,目前已经确定地确定了11个基因座,其中GWAS去年有6个。 1型排在第二,去年有五个基因座,总共11个,另外还有前列腺癌和类风湿关节炎的基因座,后者通过候选基因分析平行复制。随之而来的是奖金:解剖体重指数产生了第一个肥胖基因FTO,前列腺癌风险等位基因可保护2型糖尿病,某些高表达的2型糖尿病风险基因看起来易患结肠癌。表达不佳。这些发现-我指望通过通信告诉我们,我们忽略了其他例子-支持连通性的概念:我们的生物学不尊重经典的临床学科界限,并且关键的切换涉及维持平衡,而缺乏后的病理却大不相同或多余。这些突破的主要推动者是HapMap资源和Perlegen SNP集的开发,这是SNP联盟的早期继承者。在人类基因组计划之后,仅用了不到十年的时间,就建立了Affymetrix和Illumina强大而超高密度的SNP检测平台。而且,由于每个样本都来自相同的HapMap集,因此已经开发了工具,可以通过插补共同分析任一平台键入的大型研究样本,并通过插值计算缺失值(例如Servin和Stephens)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号